{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:09:04Z","timestamp":1780355344454,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.ajo.2007.03.050","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T09:03:25Z","timestamp":1183021405000},"page":"55-61.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Interferon-\u03b1 as an Effective Treatment for Noninfectious Posterior Uveitis and Panuveitis"],"prefix":"10.1016","volume":"144","author":[{"given":"Jarka","family":"Plskova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Forrester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2007.03.050_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0002-9394(56)91653-1","article-title":"Prednisone and prednisolone in ocular disease","volume":"41","author":"Gordon","year":"1956","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.03.050_bib2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/bjo.81.12.1107","article-title":"Immunosuppressive therapy for chronic uveitis: optimizing therapy with steroids and cyclosporin A","volume":"81","author":"Dick","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.03.050_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1167\/iovs.03-0659","article-title":"Anti-TNF-alpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation","volume":"45","author":"Greiner","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2007.03.050_bib4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archopht.122.6.845","article-title":"Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis","volume":"122","author":"Murphy","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2007.03.050_bib5","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN-alpha in autoimmune diseases","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajo.2007.03.050_bib6","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1136\/bjo.2003.037192","article-title":"Anti-TNF-alpha therapy for sight threatening uveitis","volume":"89","author":"Lindstedt","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.03.050_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.preteyeres.2004.06.005","article-title":"The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU)","volume":"23","author":"Dick","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2007.03.050_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bjo.87.4.423","article-title":"Human recombinant interferon alfa-2a for the treatment of Behcet\u2019s disease with sight threatening posterior or panuveitis","volume":"87","author":"Kotter","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.03.050_bib9","first-page":"293","article-title":"[The use of interferon alfa-2r in the treatment of autoimmune uveitis (primary or associated with Behcet\u2019s disease)]","volume":"196","author":"Sanchez Roman","year":"1996","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.ajo.2007.03.050_bib10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bjo.2004.061119","article-title":"Interferon as a treatment for uveitis associated with multiple sclerosis","volume":"89","author":"Becker","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.03.050_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.bor.0000197995.27579.9b","article-title":"New approaches in the treatment of Adamantiades-Behcet\u2019s disease","volume":"18","author":"Pipitone","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ajo.2007.03.050_bib12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1586\/14737140.4.5.823","article-title":"Adjuvant therapy for malignant melanoma","volume":"4","author":"Stoutenburg","year":"2004","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ajo.2007.03.050_bib13","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3949\/ccjm.71.Suppl_3.S3","article-title":"The evolving treatment of chronic hepatitis C: where we stand a decade out","volume":"71","author":"Saadeh","year":"2004","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.ajo.2007.03.050_bib14","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1517\/14712598.4.10.1609","article-title":"Cytokine gene therapy for malignant glioma","volume":"4","author":"Okada","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.ajo.2007.03.050_bib15","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1038\/sj.thj.6200438","article-title":"Management of the myeloproliferative disorders: distinguishing data from dogma","volume":"5","author":"Green","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.ajo.2007.03.050_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.03.050_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s001050050899","article-title":"[Depression and suicidal intentions as a side effect of high dosage interferon-alpha therapy\u2014two cases]","volume":"50","author":"Windemuth","year":"1999","journal-title":"Hautarzt"},{"key":"10.1016\/j.ajo.2007.03.050_bib18","first-page":"353","article-title":"[Suicidal impulses in patients with chronic viral hepatitis C during or after therapy with interferon-alpha]","volume":"22","author":"Rifflet","year":"1998","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.ajo.2007.03.050_bib19","first-page":"228","article-title":"Mental depression, acute infection and coma in a patient treated with interferon-alpha","volume":"74","author":"Russo","year":"1989","journal-title":"Haematologica"},{"key":"10.1016\/j.ajo.2007.03.050_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.dld.2004.09.018","article-title":"Interferon-induced depression: prevalence and management","volume":"37","author":"Scalori","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ajo.2007.03.050_bib21","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1097\/01.aids.0000192087.64432.ae","article-title":"Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week Prospective Study","volume":"19","author":"Reichenberg","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.ajo.2007.03.050_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-2005-837813","article-title":"Depression during therapy with interferon-alpha\u2014how long should an anti-depressant treatment last?","volume":"38","author":"Nickel","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ajo.2007.03.050_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/bjo.79.2.150","article-title":"Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa","volume":"79","author":"Hayasaka","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.03.050_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bjo.87.2.247","article-title":"Severe interferon associated retinopathy","volume":"87","author":"Tu","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.03.050_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/bjo.82.3.323","article-title":"Interferon associated retinopathy","volume":"82","author":"Hayasaka","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.03.050_bib26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/bjo.85.10.1171","article-title":"Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin","volume":"85","author":"Jain","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.03.050_bib27","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/bjo.2004.043968","article-title":"Is screening for interferon retinopathy in hepatitis C justified?","volume":"88","author":"Cuthbertson","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.03.050_bib28","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/bjo.2005.077537","article-title":"Retinopathy is not the only ocular symptom: myasthenia gravis in association with interferon therapy","volume":"89","author":"Oishi","year":"2005","journal-title":"Br J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939407003339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939407003339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:54:47Z","timestamp":1757595287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939407003339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0002939407003339"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2007.03.050","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-\u03b1 as an Effective Treatment for Noninfectious Posterior Uveitis and Panuveitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2007.03.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}